NEUP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

NEUPNeuphoria Therapeutics Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

NEUPNeuphoria Therapeutics Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NEUP 6

MRKMerckcustomer

—Danforth Advisorsunlistedsupplier

—Wolf & Company, P.Cunlistedsupplier

—WG Partners LLPunlistedsupplier

2 more · NEUP chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

NEUPNeuphoria Therapeutics Inc.

2.80▼−6.04%· post 2.80· delayed

Mkt cap$16.1MRevenue$15MQ3 FY25Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.00· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

NEUPNeuphoria Therapeutics Inc.

LLYELI Lilly & Co

2.80▼−6.04%post 2.80delayed

Price

1,371.32▼−3.29%post 1,363.00delayed

$16.1M

Mkt cap

$1.3T

Q3 FY25$15M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

NEUP2.80▼−6.04%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed